Users Online:
469
Home
|
About the Journal
|
Instructions
|
Current Issue
|
Back Issues
|
Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Access statistics : Table of Contents
2023| January-February | Volume 26 | Issue 1
Online since
January 25, 2023
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Viewed
PDF
Cited
LETTERS TO THE EDITOR
Tocilizumab in a child with acute leukoencephalopathy with restricted diffusion
Anshul Jaiswal, Shivani Patel, Soubhagya Khare, Gouri R Passi
January-February 2023, 26(1):95-96
DOI
:10.4103/aian.aian_795_22
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
526
25
-
AIAN REVIEW
Anti-
N
-methyl D-aspartate receptor encephalitis in India: A literature review
Debashish Chowdhury, Ashwin K Panda, Ashutosh Gupta, Samiran Chowdhury, Ashish Duggal, Arun Koul
January-February 2023, 26(1):17-32
DOI
:10.4103/aian.aian_519_22
Anti N-methyl D-aspartate receptor encephalitis (NMDAR-E) though rare, is currently considered as the commonest antibody mediated encephalitis in the world. No review on perspectives of NMDAR-E from India is available. The aim of the study was to review all the cases of NMDAR-E reported from India until June 2021 in terms of clinical features, diagnosis, and treatment, and perform a comparison of adult and paediatric cases. A literature review of NMDAR-E case reports/case series published from India till June 2021 was done. Demography, clinical profile, triggers, electroencephalography (EEG), neuroimaging, treatment details and outcomes were analysed. Sixteen case series and 35 case reports with a total of 249 cases were analysed. 82% of cases were from paediatric age group. The female to male ratio was 3:1. Psychiatric deficits, movement disorders, seizures, and language abnormalities were the most common clinical features. MRI brain abnormalities were seen in 45% patients. Electroencephalographic abnormalities were seen in 85% of patients. Infective triggers (herpes simplex virus and various other agents) were reported in 11% of the cases. Pediatric patients as compared with adults had more encephalopathy, autonomic dysfunctions, and normal imaging whereas the latter had more cognitive dysfunctions and delta brush pattern in electroencephalography (p<0.005). Therefore, to conclude, this literature review suggests that overall, the clinical spectrum of Indian cases is like cases described from other parts of the world. However, most reported cases from India belonged to paediatric age group who had more encephalopathy, autonomic dysfunctions, and normal brain imaging compared to adults. A few novel infectious agents as triggers were described from India.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
361
41
-
VIEW POINT
Disease-Modifying therapy in subacute sclerosing panencephalitis: An area of darkness
Divyani Garg, Suvasini Sharma
January-February 2023, 26(1):3-9
DOI
:10.4103/aian.aian_655_22
Subacute sclerosing panencephalitis (SSPE) is a neurodegenerative disorder because of the persistence of mutated measles virus in the central nervous system. Till date, no curative therapy has been established for SSPE. Multiple drugs have been tried to modify the disease process but have shown mild to moderate benefit at best. It is also challenging to attribute the relative success of some strategies described in single case reports because of the known phenomenon of spontaneous improvement in 5% of patients with SSPE. Critical gaps in understanding the pathophysiological processes involved exist. Current therapies such as interferon alfa require invasive strategies for administration by the intraventricular or intrathecal route, with varying dosage regimens. Oral therapies such as isoprinosine and ribavirin are expensive and not readily available in resource-constrained settings. Most of the evidence so far favors the use of combinational regimens. In this viewpoint, we critically summarize the current evidence on disease-modifying strategies in the context of our region.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
324
49
-
AIAN REVIEW
Collateral circulation- Evolving from time window to tissue window
Archana Sharma, Ayush Agarwal, Venugopalan Y Vishnu, MV Padma Srivastava
January-February 2023, 26(1):10-16
DOI
:10.4103/aian.aian_413_22
Cerebral collateral circulation refers to the auxiliary vascular structures which compensate cerebral blood flow when it has been compromised due to stenosis or occlusion of the principal supplying arteries. They play a vital role in sustaining blood flow to the ischemic areas in acute, subacute or chronic phases of ischemic stroke or TIA. Good collateral circulation has shown protective effects towards a favorable functional outcome and a lower risk of recurrence of stroke. The benchmark mechanical thrombectomy trials utilized these collateral scoring methods to guide patient selection and prognosticate favorable outcome models. This shows a promising future of the collateral circulation for extending the time frame of the reperfusion therapies by optimally guiding patient selection and moving from a “time window” to a “tissue window.”
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
299
44
-
EDITORIAL COMMENTARY
Local nerve block in meralgia paresthetica - What does the evidence suggests?
Tanushree Chawla, Vinay Goyal
January-February 2023, 26(1):1-2
DOI
:10.4103/aian.aian_981_22
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
283
42
-
LETTERS TO THE EDITOR
A rare case of hypoglossal nerve schwannoma presenting as hemiatrophy of the tongue: A case report
Mrinmayi M Zurale, Ashish Patil
January-February 2023, 26(1):76-77
DOI
:10.4103/aian.aian_876_22
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
284
13
-
ORIGINAL ARTICLES
Neurogenic supine hypertension and cardiovascular autonomic dysfunction in patients with parkinson's disease
Sunil Kapoor, Alvee Saluja, Shubha Laxmi Margekar, Mayank Agarwal, Sunita Mondal, Rajinder K Dhamija
January-February 2023, 26(1):33-38
DOI
:10.4103/aian.aian_476_22
Background:
Natural history and disease progression in patients with Idiopathic Parkinson's Disease (PD) is quite heterogeneous. Autonomic dysfunction occurs commonly among Idiopathic PD patients. Heart rate variability and ambulatory blood pressure monitoring are used to assess cardiac autonomic dysfunction. The prevalence and magnitude of supine hypertension in Indian PD patients has not been studied to date. The present study aimed to record cardiovascular autonomic functions and supine hypertension in PD patients and to correlate them with the age of onset, duration and severity of the disease, and non-motor symptom burden.
Material and Methods:
The cross-sectional study involved 60 PD patients. Webster rating scale was used to determine the disease severity. Non-motor symptom burden was assessed using the Non-Motor Symptom Scale (NMSS). Ambulatory blood pressure monitoring and heart rate variability parameters determined cardiac autonomic function. Supine hypertension was defined as Systolic Blood Pressure (SBP) ≥150 mmHg and/or DBP ≥90 mmHg. Less than 10% decrease or even increase in blood pressure during the night were classified as non-dippers. Pearson coefficient was used appropriately to establish correlation.
P
≤ 0.05 was considered significant.
Results:
Age of onset was 61.2 ± 8.7 years and duration of disease was 1.7 ± 1.1 years. Mean Webster and non-motor symptom scores were 12.7 ± 4.4 and 15.5 ± 8.0, respectively. About 50 patients (83%) were non-dipper, while 32 (53%) had supine hypertension. Low Frequency oscillations (LF) (r = 0.28), High Frequency oscillations (HF) (r = 0.29), Standard Deviation NN intervals (SDNN) (0.26), and Root Mean Squared Successive Differences of NN intervals (RMSSD) (r = 0.28) correlated significantly with non-motor symptoms scale. LF (r = −0.39), HF (r = −0.43), SDNN (−0.40), RMSSD (r = −0.41), NN50 (r = −0.38), PNN50 (r = −0.42), mean SBP (r = 0.26), and mean DBP (r = 0.33) correlated significantly with disease duration. PNN50 (r = −0.255), mean SBP (r = −0.29), and mean DBP (r = −0.27) correlated significantly with age at onset.
Conclusion:
Awareness regarding neurogenic supine hypertension is needed as it occurs commonly among Indian PD patients. Heart rate variability (HRV) parameters and ambulatory blood pressure are of significant help in the detection of early cardiovascular autonomic dysfunction and correlate significantly with disease duration and non-motor symptom burden among PD patients.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
259
18
-
Biosimilar tenecteplase versus alteplase in acute ischemic stroke: A real world study
Ayush Mohan, Snigdha Komakula, Suhas Murali, Pooja Anand, Dyuti Shah, VY Vishnu, Awadh Kishor Pandit, Ayush Agarwal, Deepti Vibha, Mamta Bhushan Singh, MV Padma Srivastava, Rohit Bhatia
January-February 2023, 26(1):54-58
DOI
:10.4103/aian.aian_754_22
Background and Purpose:
There is an unmet need for a more effective thrombolytic agent in acute ischemic stroke (AIS) management. Various studies and meta-analysis suggest tenecteplase (TNK) as non-inferior over alteplase (rTPA). The present single-center study compares biosimilar TNK and rTPA in a tertiary care setting.
Methods:
Data of patients who presented with AIS and underwent intravenous thrombolysis (IVT) were recruited retrospectively from January 2018 to July 2021. Primary efficacy outcome was a modified Rankin score (mRS) at 90 days dichotomized at < = 2. Qualitative and quantitative variables were assessed using Chi-square test and Student's t-test, respectively.
Results:
A total of 160 patients, 103 in the rTPA and 57 in TNK group, were analyzed. The baseline characteristics were well matched apart from hypertension. Large artery atherosclerosis was the most frequent subtype of stroke among the two groups. Good functional outcome was seen in 47.92% of patients TNK and 64.77% of patients in rTPA group (p = 0.069). No difference was seen in the rates of any ICH (p = 0.29) and mortality at 3 months (p = 0.32) among the two groups.
Conclusion:
This present study observed no difference in the efficacy and safety between biosimilar TNK and rTPA. Our findings are in concordance with published trials showing equivalence between the two molecules.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
232
22
-
Non-Motor symptoms burden in early stages of parkinson's disease
Zomer Sardar, Sumayyah Liaquat, Qudsum Yousaf, Safia Bano, Ahsan Numan
January-February 2023, 26(1):39-43
DOI
:10.4103/aian.aian_483_22
Background:
Non-motor symptoms (NMSs) in Parkinson's disease (PD) are often overlooked and thus can impede clinical management and significantly reduce the patient's quality of life.
Aims:
The study aimed to determine the burden of NMS in the early stages of PD.
Material and Methods:
A 1-year observational cross-sectional study was conducted at Mayo Hospital, Lahore, in 2019. The MDS-PD criteria were used to diagnose PD patients. The study included patients with Hoehn and Yahr (HY) stages 1–3. The frequency of NMSs was assessed using a non-motor symptom questionnaire (NMSQ), and the non-motor symptom scale (NMSS) score was derived using the NMSS.
Results:
A total of 100 PD patients were enrolled in the study. Sixty-three (63%) were males and 37 (37%) were females. Their age ranged between 45 and 75 years with a mean ± SD of 57.46 ± 8.46. At least one NMS was reported by 84% of patients, with neuropsychiatric symptoms (68%) preponderant, followed by a change in taste and smell (64%). The mean NMSS score is 46.22 ± 22.098 (median 44) with a range from 0 to 88, with the trend being increasing score with the advancing stage.
Conclusion:
The use of the NMSQ and NMSS tools should be standard in clinical practice to identify the severity of the disease and commence appropriate care.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
230
19
-
Effect of early yoga practice on post stroke cognitive impairment
Manshi Kashyap, Nirendra K Rai, Ruchi Singh, Ankur Joshi, Abhijit R Rozatkar, Priyanka V Kashyap, Shweta Mishra, Sofia Mudda
January-February 2023, 26(1):59-66
DOI
:10.4103/aian.aian_808_22
Background:
Post-stroke cognitive impairment (PSCI) is a clinical entity that encompasses all types of cognitive impairment following an index stroke. Yoga has been proven to have a beneficial effect not only on cardiovascular risk factors but also on cognition. Hence, this study explored the PSCI spectrum and assessed the effect of yoga on PSCI.
Methods
: Forty stroke patients were enrolled in each yoga and control arm in this study. After the baseline assessment, control arm was administered standard care (including physiotherapy) while yoga arm received additional yoga intervention. Change in MoCA scores by 2 points in either direction, or FAB scale by 2 points at 6 months was taken as primary outcome, whereas improvement in MRS, CDPSS, CBS, and P300 values were considered as secondary outcomes.
Results
: Significant improvements were observed in MoCA, FAB, MRS, CPDSS, and CBS scores in both groups after 6 months. However, intergroup comparisons revealed better MoCA (25.5, IQR 22-27) and FAB scores (15.5, IQR 14-17) in yoga group compared to controls (24, IQR20-25.75) and (14, IQR12-15.75). Equivalent improvement was observed in MRS and CBS scores in both groups at 6 months; however, CDPSS score was better in yoga group (p = 0.0008). Both P300 amplitudes and latencies improved in all patients and median P300 amplitudes were significantly better in control group; however, no difference could be appreciated in P300 latencies improvement on intergroup comparisons at follow-up.
Conclusion
: Study reveals that early yoga intervention in stroke survivors leads to better improvement in cognitive abilities which would further facilitate in early reduction of caregiver burden.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
222
20
-
LETTERS TO THE EDITOR
Pure Arterial Malformation (PAM): Case report and review of literature
Aviraj S Deshmukh, Christine Hawkes, Brian Van Adel
January-February 2023, 26(1):87-88
DOI
:10.4103/aian.aian_797_22
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
224
10
-
CASE REPORT
Mitochondrial calcium uptake 1 (MICU1) gene-related myopathy with extrapyramidal signs: A clinico-radiological case report from India
Debaleena Mukherjee, Adreesh Mukherjee, Subhadeep Gupta, Souvik Dubey, Alak Pandit
January-February 2023, 26(1):73-75
DOI
:10.4103/aian.aian_904_22
Myopathy with extrapyramidal signs (MPXPS) is a rarely reported entity worldwide, manifesting as a muscular dystrophy with movement disorders. It results from mutations in the mitochondrial calcium uptake 1 (
MICU1
) gene. We hereby describe a 17-year-old boy who presented with proximal myopathy, calf muscle hypertrophy, and skeletal deformities along with choreiform movements of his upper extremities. Muscle MRI revealed a distinctively early involvement of adductors with sparing of antero-lateral compartment of thigh. This report expands the clinico-radiological presentation and to the best of our knowledge, is the first report of MICU-related MPXPS from India.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
211
14
-
ORIGINAL ARTICLES
Normative scores for malayalam cognitive screening test battery among older adults in Kerala, India
Priya Jyothishmathy Radhakrishnan, Sreelakshmi Pallipurath Raghunath, Devi Mohan, Reeja Rajan, Thomas Iype
January-February 2023, 26(1):44-53
DOI
:10.4103/aian.aian_695_22
Background:
Many neuropsychological tests are primarily developed in high-income countries, and normative data are not readily available for low- and middle-income countries (LMICs). We need culturally appropriate cognitive screening tests for India.
Objective:
Hence, we decided to translate the Hindi cognitive screening test battery (HCSTB) tool to Malayalam and establish the age and education-stratified norms for a Malayalam cognitive screening test battery (MCSTB).
Material and Methods:
HCSTB was translated to Malayalam, back-translated by bilinguals conversant in Malayalam and English, and pretested on 30 older normal adults. Using a multistage sampling technique, we conducted a descriptive cross-sectional survey in the Thiruvananthapuram district of Kerala, India. We approached older adults aged ≥60 years for informed and written consent. We excluded subjects with depression, functional impairment, cognitive impairment, history of stroke, psychosis, and visual/hearing loss that impaired cognitive assessment.
Results:
The normative data were derived from 441 older adults: 226 (51%) from rural areas and 215 (49%) from urban areas. Age and education affected the cognitive scores. The time to administer MCSTB among normal adults was approximately 17 minutes.
Discussion and Conclusion:
The derived normative data showed lower values than the published literature. A limitation of our study was the small number of older people with ≥12 years of education and the lack of neuroimaging of the subjects.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
190
22
-
Ultrasound-Guided treatment of meralgia paresthetica: With or without corticosteroid? A double-blinded, randomized controlled study
Deniz Palamar, Rana Terlemez, Tugce Ozekli Misirlioglu, Filiz Yıldız Aydın, Kenan Akgun
January-February 2023, 26(1):67-72
DOI
:10.4103/aian.aian_883_22
Background:
Blockade of the lateral femoral cutaneous nerve (LFCN) with local anesthetic (LA) has therapeutic role as well as diagnostic value for meralgia paresthetica (MP). The aim of this study was to compare the effectiveness of ultrasound-guided LA and LA + CS injections in the treatment of MP.
Methods:
This was a prospective, double-blinded, randomized controlled study. Thirty-two patients were evaluated clinically, and electrophysiologically and diagnosed as MP by diagnostic block. They were randomly assigned to two groups and all patients completed the study. The first group (
n
= 17) received 2 mL of lidocaine 2%+1 mL of betamethasone, while the second group (
n
= 15) received 2 mL of lidocaine 2% + 1 mL saline solution.
Results:
No statistically significant difference was detected between the groups in numeric rating scale (NRS) values. In both groups, NRS values were significantly decreased after the injection that confirms the diagnosis of MP. The improvement continued on the following weeks in both groups. At the 4
th
week, the NRS value reached to 2.47 in the CS group and reached to 3.13 in the LA group.
Conclusions:
Both CS and LA injections for the treatment of MP were found to be clinically effective and both may be therapeutic options. In intractable cases, once the nerve block is applied with or without CS, well-being can be achieved by keeping the patient away from the triggering factors. To provide effective and isolated injection of LFCN, that may have frequent anatomical variations, ultrasonography guidance could be suggested.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
173
17
-
LETTERS TO THE EDITOR
Rapidly progressive ALS with atypical parkinsonism: An unusual case of multisystem proteinopathy from India
Hiral A Halani, Pankaj K Saini, Priyanka Chavan, Khushnuma A Mansukhani, Satish V Khadilkar
January-February 2023, 26(1):85-86
DOI
:10.4103/aian.aian_819_22
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
166
23
-
Parkinson's disease: The dirty truth about the air
Fulvio A Scorza, Antonio-Carlos G de Almeida, Carla A Scorza, Josef Finsterer
January-February 2023, 26(1):84-85
DOI
:10.4103/aian.aian_839_22
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
164
18
-
Intracerebral hemorrhage and absence of pneumonia are independent predictors for nasogastric tube removal of post-stroke dysphagia
Zi Ke, Wei Liu, Fu-Yan Chen, Wen-Yi Ge, Xing-Ping Li, Xiao-Nong Fan, Bang-Qi Wu
January-February 2023, 26(1):90-93
DOI
:10.4103/aian.aian_809_22
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
168
8
-
Obstructive hydrocephalus as the solitary manifestation of young onset erdheim–Chester disease
Shreyashi Jha, Dipti Baskar, BN Nandeesh, Seena Vengalil, Ravindranadh Chaudhary, Atchayaram Nalini, Ravi Yadav, Dwarkanath Srinivas
January-February 2023, 26(1):77-80
DOI
:10.4103/aian.aian_537_22
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
156
10
-
Cutis Verticis Gyrata Heralding a Diagnosis of Primary Systemic Amyloidosis in a Patient with Cardioembolic Stroke
Ayush Agarwal, Pinki Chatterpal, Surya Kant, Ajay Garg, Sudheer Arava, Achal K Srivastava
January-February 2023, 26(1):88-90
DOI
:10.4103/aian.aian_730_22
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
140
17
-
Aegrescit medendo (Worsens with Treatment)–Propofol frenzy
Boby V Maramattom
January-February 2023, 26(1):93-94
DOI
:10.4103/aian.aian_851_22
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
114
12
-
Diagnosing leber's hereditary optic neuropathy requires documentation of a causative mtDNA variant
Josef Finsterer
January-February 2023, 26(1):80-81
DOI
:10.4103/aian.aian_863_22
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
108
12
-
Application of 3D printing in individualized treatment of intracranial aneurysms
Sen Wang, Qing Huang, Jing Yuan, HongBing Zhang, Nan Yang, Zhicheng Pang
January-February 2023, 26(1):81-84
DOI
:10.4103/aian.aian_133_22
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
110
10
-
About this journal
Editorial Board
Online Submission
Current Issue
Archives
Ahead of print
Instructions to Authors
Subscription
Alerting
Feedback
About us
|
Contact us
|
Ahead Of Print
|
Online Submission
|
Sitemap
|
Advertise
|
What's New
|
Feedback
|
Disclaimer
|
Privacy Notice
© 2006 - Annals of Indian Academy of Neurology | Published by Wolters Kluwer -
Medknow
Online since 1
st
March, 2006